Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Onyinyechi C. Onyeador"'
Autor:
Huiming Xia, Joshua McMichael, Michelle Becker-Hapak, Onyinyechi C. Onyeador, Rico Buchli, Ethan McClain, Patrick Pence, Suangson Supabphol, Megan M. Richters, Anamika Basu, Cody A. Ramirez, Cristina Puig-Saus, Kelsy C. Cotto, Jasreet Hundal, Susanna Kiwala, S. Peter Goedegebuure, Tanner M. Johanns, Gavin P. Dunn, Antoni Ribas, Christopher A. Miller, William E. Gillanders, Todd A. Fehniger, Obi L. Griffith, Malachi Griffith
Publikováno v:
Cancer Genetics. :11-12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c875dd5ca788504819d40903bfb664ef
https://doi.org/10.1016/j.cancergen.2022.10.036
https://doi.org/10.1016/j.cancergen.2022.10.036
Autor:
Cody A. Ramirez, Felix Frenkel, Michelle Becker-Hapak, Erica K. Barnell, Ethan D. McClain, Sweta Desai, Timothy Schappe, Onyinyechi C. Onyeador, Olga Kudryashova, Vladislav Belousov, Alexander Bagaev, Elena Ocheredko, Susanna Kiwala, Jasreet Hundal, Zachary L. Skidmore, Marcus P. Watkins, Thomas B. Mooney, Jason R. Walker, Kilannin Krysiak, David A. Russler-Germain, Felicia Gomez, Catrina C. Fronick, Robert S. Fulton, Robert D. Schreiber, Neha Mehta-Shah, Amanda F. Cashen, Brad S. Kahl, Ravshan Ataullakhanov, Nancy L. Bartlett, Malachi Griffith, Obi L. Griffith, Todd A. Fehniger
Personalized cancer vaccines designed to target neoantigens represent a promising new treatment paradigm in oncology. In contrast to classical idiotype vaccines, we hypothesized that ‘polyvalent’ vaccines could be engineered for the personalized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b922592ebecde45a7413123710bd2365
https://doi.org/10.1101/2022.01.06.22268805
https://doi.org/10.1101/2022.01.06.22268805
Autor:
Huiming Xia, Joshua McMichael, Michelle Becker-Hapak, Onyinyechi C. Onyeador, Rico Buchli, Ethan McClain, Patrick Pence, Suangson Supabphol, Megan M. Richters, Anamika Basu, Cody A. Ramirez, Cristina Puig-Saus, Kelsy C. Cotto, Jasreet Hundal, Susanna Kiwala, S. Peter Goedegebuure, Tanner M. Johanns, Gavin P. Dunn, Antoni Ribas, Christopher A. Miller, William Gillanders, Todd A. Fehniger, Obi L. Griffith, Malachi Griffith
Publikováno v:
Cancer Research. 82:5639-5639
Neoantigens are novel peptide sequences resulting from somatic mutations in tumors that upon loading onto major histocompatibility complex (MHC) molecules allow recognition by T cells. Accurate neoantigen identification is thus critical for designing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c59df0f9f2567690e42d328031aba4ef
https://doi.org/10.1158/1538-7445.am2022-5639
https://doi.org/10.1158/1538-7445.am2022-5639
Autor:
Huiming Xia, Joshua McMichael, Michelle Becker-Hapak, Onyinyechi C. Onyeador, Rico Buchli, Ethan McClain, Patrick Pence, Suangson Supabphol, Megan M. Richters, Anamika Basu, Cody A. Ramirez, Cristina Puig-Saus, Kelsy C. Cotto, Sharon L. Freshour, Jasreet Hundal, Susanna Kiwala, S. Peter Goedegebuure, Tanner M. Johanns, Gavin P. Dunn, Antoni Ribas, Christopher A. Miller, William E. Gillanders, Todd A. Fehniger, Obi L. Griffith, Malachi Griffith
Neoantigens are novel peptide sequences resulting from sources such as somatic mutations in tumors. Upon loading onto major histocompatibility complex (MHC) molecules, they can trigger recognition by T cells. Accurate neoantigen identification is thu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a22daced7bed0c79e46a277b6d32460a
https://doi.org/10.1101/2020.12.08.416271
https://doi.org/10.1101/2020.12.08.416271